Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community-level early warning system for the disease, ...

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature ...

Background Individual screening for colorectal cancer (CRC) is typically performed through either direct clinical examination ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

GRAND RAPIDS, Mich. — BAMF Health, a cancer treatment center in Grand Rapids, has launched a study to better understand a certain type of breast cancer. The non-invasive study seeks to find whether or ...

Catching pancreatic cancer early is among the most difficult challenges faced by medical providers, and that delay often ends in death. The NIH-supported researchers’ discovery of a new blood test, ...

A new kind of cancer test could soon change how doctors detect deadly diseases—quickly, cheaply, and almost anywhere. A team of researchers has designed a small, low-cost device that can identify ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...

Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community level early warning system for the disease, suggests a proof of ...

Cervical squamous cell carcinoma is one of the predominant histological subtypes of cervical cancer, with significant morbidity and mortality globally. Its management increasingly relies on the ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream ...